1. Sun Pharma Advanced Research
stock logo

100% Buy

Sun Pharma Advanced Research Share Price

SPARC

₹224.57-₹1.49 (-0.66%) TodayLast updated on 16 Sep, 2024 | 15:56 IST
Please wait...
  • News

  • Company overview

  • Fundamentals

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹7,336 Crs

Open

₹227.30

Close

₹226.06

Circuit range

₹271.27 - ₹180.84

Day range

₹223.40 - ₹227.65

Year range

₹196.10 - ₹472.80

Volume

2,99,462

Avg. traded

₹225.03

Revenue (12m)

₹68 Crs

Sun Pharma Advanced ResearchSun Pharma Advanced Research Company Limited is an India-based clinical-stage biopharmaceutical company that focuses on developing therapeutics to improve standards of care for patients worldwide. The Company’s therapeutic focus is in the area of oncology, neurology and immunology. Its lead oncology programs include vodobatinib (SCO-088), a BCR-ABL targeting tyrosine kinase inhibitor for refractory chronic myelogenous leukemia, and an anti-MUC-1 antibody-drug conjugate (ADC) with the potential to treat multiple cancers. Its lead therapeutic agent, vodobatinib (SCC-138), is a c-ABL inhibitor that has the potential to be a therapy modulating cellular homeostasis in neurodegenerative diseases. Vibozilimod (SCD-044) is a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist targeting autoimmune disorders. SCD-153 is a topical agent being developed for the treatment of alopecia areata. SBO-154 is an ADC being developed for multiple tumor types expressing MUC-1.

Sun Pharma Advanced Research Key indicators

arrow

52 week high

₹472.80

52 week low

₹196.10

P/E ratio

P/B ratio

243.6

ROE

-121.73%

ROCE

-112.88%

Dividend yield

--

Debt/Equity ratio

0.38

EPS

-11.96

Learn more

Investment checklist: (1/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

-495.49%

Net profit margin

-513.74%

ROE

-121.73%

ROA

-58.96%

ROCE

-112.88%

Learn more

Sun Pharma Advanced Research Shareholder returns

arrow

1 day

+0.31%

1 week

+0.15%

1 month

+4.80%

3 months

-3.56%

1 year

-8.11%

3 years

-22.44%

5 years

+40.54%

Sun Pharma Advanced Research Share Price history

arrow
DayOpenCloseDay’s change
Fri, Sep 13 2024
₹226.75
₹226.06
+0.31%
Thu, Sep 12 2024
₹226.00
₹225.36
+0.55%
Wed, Sep 11 2024
₹231.00
₹224.12
-2.93%
Tue, Sep 10 2024
₹235.49
₹230.89
-0.06%
Mon, Sep 9 2024
₹225.72
₹231.02
+2.35%
Fri, Sep 6 2024
₹228.50
₹225.72
+0.53%
Thu, Sep 5 2024
₹226.90
₹224.54
-0.54%
Wed, Sep 4 2024
₹220.77
₹225.76
+2.26%

Shareholding info

arrow

Promoters (65.67%)

Mutual Funds (0.25%)

Retail and other (30.42%)

Foreign institutions-FII (3.24%)

Other domestic institutions (0.41%)

Promoters

Learn more

Frequently asked questions